论文信息 - Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study - 字舞流文

Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study

C. Pozzilli | J. Hobart | B. Uitdehaag | A. Traboulsee | G. Comi | D. Pelletier | T. Ziemssen | S. Schippling | V. Limmroth | Zia Choudhry | L. Sousa | S. Eichau | B. van Wijmeersch | A. Bass | C. Laganke | R. Berkovich | S. Hunter | N. Daizadeh | B. Singer